{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:43:49Z","timestamp":1762955029257,"version":"3.44.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Sanofi Pasteur MSD (Lyon, France)"},{"DOI":"10.13039\/100008363","name":"Danish Cancer Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"crossref"}]},{"name":"MERMAID"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.ygyno.2011.10.020","type":"journal-article","created":{"date-parts":[[2011,10,26]],"date-time":"2011-10-26T21:03:05Z","timestamp":1319662985000},"page":"281-285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["HPV16 is associated with younger age in women with cervical intraepithelial neoplasia grade 2 and 3"],"prefix":"10.1016","volume":"124","author":[{"given":"L.","family":"Baandrup","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Munk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.K.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Junge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Iftner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.K.","family":"Kj\u00e6r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2011.10.020_bb0005","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2011.10.020_bb0010","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/jnci\/djq356","article-title":"Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence","volume":"102","author":"Kjaer","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2011.10.020_bb0015","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.10.020_bb0020","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1086\/428850","article-title":"Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica","volume":"191","author":"Herrero","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ygyno.2011.10.020_bb0025","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/ijc.23712","article-title":"Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark","volume":"123","author":"Kjaer","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.10.020_bb0030","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1158\/1055-9965.EPI-10-0251","article-title":"Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3","volume":"19","author":"Castle","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2011.10.020_bb0035","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1158\/1055-9965.EPI-10-1267","article-title":"Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California","volume":"20","author":"Castle","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2011.10.020_bb0040","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1158\/1055-9965.EPI-08-0951","article-title":"Human papillomavirus types by age in cervical cancer precursors: predominance of human papillomavirus 16 in young women","volume":"18","author":"Porras","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2011.10.020_bb0045","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1158\/0008-5472.CAN-07-2754","article-title":"Type-dependent integration frequency of human papillomavirus genomes in cervical lesions","volume":"68","author":"Vinokurova","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2011.10.020_bb0050","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.24075","article-title":"Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype","volume":"124","author":"de Cremoux","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.10.020_bb0055","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn510","article-title":"Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States","volume":"101","author":"Wheeler","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2011.10.020_bb0060","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/oxfordjournals.jncimonographs.a003487","article-title":"Chapter 12: human papillomavirus technologies","volume":"31","author":"Iftner","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.ygyno.2011.10.020_bb0065","unstructured":"Vernick JP, Steigman CK. The HPV DNA virus hybrid capture assay: what is it\u2013and where do we go from here? MLO Med Lab Obs 2003;35:8\u201310,13."},{"key":"10.1016\/j.ygyno.2011.10.020_bb0070","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.virol.2005.04.002","article-title":"The carcinogenicity of human papillomavirus types reflects viral evolution","volume":"337","author":"Schiffman","year":"2005","journal-title":"Virology"},{"isbn-type":"print","year":"2005","series-title":"R: a language and environment for statistical computing, reference index version 2.2.1","key":"10.1016\/j.ygyno.2011.10.020_bb0075","ISBN":"https:\/\/id.crossref.org\/isbn\/3900051070"},{"key":"10.1016\/j.ygyno.2011.10.020_bb0080","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"Khan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2011.10.020_bb0085","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1016\/j.vaccine.2009.06.102","article-title":"Implementation of the Australian HPV vaccination program for adult women: qualitative key informant interviews","volume":"27","author":"Leask","year":"2009","journal-title":"Vaccine"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811008626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811008626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:28:57Z","timestamp":1758770937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825811008626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0090825811008626"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.10.020","relation":{},"ISSN":["0090-8258"],"issn-type":[{"type":"print","value":"0090-8258"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HPV16 is associated with younger age in women with cervical intraepithelial neoplasia grade 2 and 3","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}